Benefits
Digestive comfort and stool regularity
In 61 adults with gas-related discomfort after meals, 4 weeks of a capsule combining BC30 with digestive enzymes improved abdominal pain and total symptom scores versus placebo, but bloating only trended better and a strong placebo response left many outcomes unchanged. In 111 healthy adults with digestive complaints, 4 weeks of BC30 alone raised weekly stool count and improved stool consistency versus placebo.
Amino acid absorption from protein shakes
In two small crossover trials, adding BC30 to a daily protein shake for 2 weeks raised blood amino acid levels after the final shake compared with protein alone. One tested a rice and pea protein blend in 30 healthy women averaging 58.5 years old; the other tested milk protein in 30 younger men and women. Both included co-authors from Increnovo LLC.
Perceived recovery and muscle soreness after hard exercise
In 29 trained men, 2 weeks of BC30 with 20 g of casein improved perceived recovery and lowered soreness after a muscle-damaging workout compared with casein alone, in a single-blind, non-randomized, maker-funded study. In 18 soldiers taking HMB, a randomized trial found an imaging measure linked to muscle integrity was better when BC30 was added. Both were small trials.
Joint comfort scores alongside standard care
A 60-day pilot in 45 adults with rheumatoid arthritis who kept taking their usual medication found a significant improvement on one pain scale and a borderline result for patient pain assessment (p = 0.052) versus placebo. The caplet combined BC30 with green tea extract, MSM, vitamins and minerals, so the effect cannot be credited to BC30 alone, and it is not evidence that BC30 treats any disease.
Taken as dormant spores in capsules, sachets or shakes
BC30 is taken as dormant spores. Researchers describe the spores becoming active after they germinate in the small intestine. In the cited trials it was given as a daily capsule, as a powder sachet, and mixed into protein shakes.
Upper respiratory symptoms in school-age children
In 80 healthy children aged 6 to 8, 1 billion CFU of BC30 daily for 3 months lowered how often some upper respiratory symptoms occurred, such as nasal congestion and hoarseness, and shortened some others compared with placebo. In 36 adults aged 65 to 80, a crossover trial found IL-10 rose during the BC30 period but no overall difference from placebo. Each result comes from a single trial.
Mechanism of action
Spore-form survival and intestinal germination
Endospores formed by Bacillus coagulans are highly resistant to heat, gastric acid, and bile. Spores transit the stomach largely intact, then germinate in the small intestine where vegetative cells become metabolically active, producing lactic acid and other fermentation products that influence the local microbial environment.
Lactic acid production
Bacillus coagulans is a lactic acid-producing bacterium. Once the spores germinate, the active cells are thought to ferment carbohydrates into lactic acid, which may shift conditions in the gut toward beneficial bacteria. In older adults, BC30 raised Faecalibacterium prausnitzii slightly more than placebo did.
Signals to the immune system
In the children's trial, symptom changes went along with shifts in several immune-related blood proteins, and in older adults IL-10 rose during BC30 use without differing from placebo overall. How BC30 interacts with gut immune tissue in people has not been worked out, so this remains a proposed mechanism.
Help with protein digestion
Laboratory work cited in the milk-protein study found BC30 increased protein digestion in a model of the stomach and small intestine. The authors propose that the active cells help break down protein and carbohydrate, which would fit the higher blood amino acid levels seen when BC30 was added to protein shakes.
Clinical trials
Randomized, double-blind, placebo-controlled trial at two sites; a capsule of 2 billion CFU BC30 plus a digestive enzyme blend, or placebo, for 4 weeks. (Kalman et al. 2009, BMC Gastroenterol)
61 adults with gas-related symptoms after meals and no digestive diagnosis.
The product improved the GSRS abdominal pain score (p = 0.046) and GSRS total score (p = 0.048) versus placebo. Bloating (distension) only trended better (p = 0.061), and the authors note a strong placebo effect that left many outcomes without a significant difference between groups. Because the capsule also held enzymes, the effect cannot be credited to BC30 alone.
Randomized, double-blind, placebo-controlled trial in China; 1 billion CFU BC30 or placebo daily for 4 weeks. Several authors work for Kerry. (Gang et al. 2025, Benef Microbes)
111 healthy adults aged 18 to 65 with digestive complaints.
BC30 increased the number of stools per week (p = 0.036), improved stool consistency and reduced the share of participants with constipation compared with placebo. It produced small changes in gut bacteria and was well tolerated.
Single-blind, non-randomized study: participants took 20 g casein daily for 2 weeks, then after a 1-week washout 20 g casein plus 1 billion CFU BC30 for 2 weeks, with a damaging exercise bout after each period. Funded by Ganeden; two authors are Increnovo employees. (Jäger et al. 2016, PeerJ)
29 recreationally trained men.
BC30 improved perceived recovery at 24 and 72 hours and reduced soreness at 72 hours compared with casein alone, and peak power was maintained. Creatine kinase, a muscle damage marker, only trended lower (p = 0.08), and swelling and blood urea nitrogen did not differ. The fixed order means a training or order effect cannot be ruled out.
Randomized, double-blind crossover trial; 20 g rice and pea protein with 1 billion CFU BC30 or a maltodextrin placebo daily for 2 weeks each, with a 3-week washout; products supplied by Kerry. (Walden et al. 2024, Probiotics Antimicrob Proteins)
30 healthy women, average age 58.5.
Adding BC30 gave a larger area under the curve for essential and total amino acids, alanine, tryptophan and cysteine, and higher peak levels for several, compared with protein alone. Time to peak was similar for most amino acids.
Randomized, double-blind, placebo-controlled trial; 1 billion CFU BC30 or maltodextrin placebo daily for 3 months. (Anaya-Loyola et al. 2019, Food Res Int)
80 healthy children aged 6 to 8 in Mexico.
BC30 lowered the incidence of several upper respiratory symptoms, including nasal congestion, itchy nose and hoarseness, shortened the duration of others, and reduced flatulence, alongside changes in serum immune-related proteins.
Randomized trial over 40 days of training; calcium HMB with BC30 or calcium HMB with placebo, plus an unsupplemented control group. (Gepner et al. 2017, J Appl Physiol (1985))
26 soldiers during intense military training (9 per supplement group, 8 controls).
Apparent diffusion coefficients, an imaging measure the authors use for muscle integrity, were significantly lower with BC30 plus HMB than with HMB alone. Inflammatory cytokines were lower than in controls with both HMB products, and IL-10 was lower than controls only with BC30 plus HMB. The trial was small, and BC30 was not tested without HMB.